Pharmaceutical procurement for oncology patients. Estudio Olaechea is assisting Pharmaris Perú with a contract arising from a corporate purchase made by Cenares and Dirsapol for the acquisition of certain pharmaceutical products for oncology patients. Cenares is the Peruvian government entity responsible for the procurement and distribution of strategic health resources, while Dirsapol is the health services directorate of the Peruvian National Police.
Ensuring timely delivery: With our assistance, the client was able to deliver certain products to the purchasing entities and, as of now, to remain within the deadline for submitting the remaining pharmaceutical products.
Addressing delivery challenges: This matter was highly complex due to delays beyond the client’s control in the delivery of pharmaceutical products. The client drafted letters duly justifying the delay and making delivery commitments with the entities. Throughout the process, we have been holding meetings with the public entity to explain the reasons for the delay.
Growing pharmaceutical leader in the Americas: Pharmaris began its commercial operations in Peru in 2009 and it expanded to Chile in 2014. Subsequently to Colombia, Canada, Bolivia, Ecuador, Mexico, United States and Venezuela. Pharmaris is part of a group of companies with over 325 employees working at hospital businesses, wholesalers, retailers and online commerce.
Latest development: We continue assisting the client with the matter.
